Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Amortizatization of Intangibles (2020 - 2024)

Immuneering has reported Amortizatization of Intangibles over the past 5 years, most recently at $124886.0 for Q4 2024.

  • Quarterly results put Amortizatization of Intangibles at $124886.0 for Q4 2024, up 142.39% from a year ago — trailing twelve months through Dec 2024 was $146837.0 (up 184.28% YoY), and the annual figure for FY2025 was $345103.0, up 5.09%.
  • Amortizatization of Intangibles for Q4 2024 was $124886.0 at Immuneering, up from $7317.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for IMRX hit a ceiling of $124886.0 in Q4 2024 and a floor of -$294643.0 in Q4 2023.
  • Median Amortizatization of Intangibles over the past 5 years was $8770.0 (2020), compared with a mean of $6129.8.
  • Biggest five-year swings in Amortizatization of Intangibles: plummeted 513.68% in 2022 and later surged 202.18% in 2023.
  • Immuneering's Amortizatization of Intangibles stood at $24760.0 in 2020, then skyrocketed by 52.19% to $37683.0 in 2021, then soared by 107.07% to $78032.0 in 2022, then crashed by 477.59% to -$294643.0 in 2023, then surged by 142.39% to $124886.0 in 2024.
  • The last three reported values for Amortizatization of Intangibles were $124886.0 (Q4 2024), $7317.0 (Q3 2024), and $7317.0 (Q2 2024) per Business Quant data.